Bcl‐2 Inhibitors Enhance FGFR Inhibitor‐induced Mitochondrial‐dependent Cell Death in FGFR 2 Mutant Endometrial Cancer

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12422
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

PI3K Inhibitors Synergize With FGFR Inhibitors to Enhance Antitumor Responses in FGFR2 Mutant Endometrial Cancers

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

Mitochondrial Signaling in Cell Death via the BCL-2 Family

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2010English

Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models

International Journal of Cancer
Cancer ResearchOncology
2019English

Targeting FGFR Signaling in Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

BCL-2 Prevents Caspase-Independent Cell Death

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Small Peptides Against the Mutant SOD1/Bcl-2 Toxic Mitochondrial Complex Restore Mitochondrial Function and Cell Viability in Mutant SOD1-Mediated ALS

Journal of Neuroscience
Neuroscience
2013English

BCL-2-Associated Athanogene 5 (BAG5) Regulates Parkin-Dependent Mitophagy and Cell Death

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Inhibition of Glutathione Synthesis Overcomes BCL-2-Mediated Topoisomerase Inhibitor Resistance and Induces Nonapoptotic Cell Death via Mitochondrial-Independent Pathway

Cancer Research
Cancer ResearchOncology
2006English

Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy